Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depression Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04994470
What this trial is testing

Web-based Self-help Intervention for Adolescents With Acute or Remitted Major Depressive Disorder

Who this might be right for
DepressionDepressive DisorderDepressive Symptoms+1 more
Ludwig-Maximilians - University of Munich 86
Not applicableUnknownNCT06279936
What this trial is testing

Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID

Who this might be right for
Long COVID
Universiteit Antwerpen 130
Not applicableLooking for participantsNCT07561632
What this trial is testing

Predictive Value of Early Peritraumatic Distress Screening for Childbirth-PTSD Following Unplanned Cesarean Delivery

Who this might be right for
Post Traumatic Stress DisorderPost Partum DepressionAcute Stress Symptoms
University of British Columbia 420
Testing effectiveness (Phase 2)Study completedNCT02094898
What this trial is testing

Ketamine for Depression and Suicide Risk

Who this might be right for
DepressionSuicide
Mayo Clinic 12
Not applicableUnknownNCT05753202
What this trial is testing

TDCS in Post-COVID Syndrome: Comparison of Two Targets

Who this might be right for
COVID-19Post-COVID-19 SyndromePost COVID-19 Condition
Hospital San Carlos, Madrid 40
Testing effectiveness (Phase 2)Study completedNCT00001483
What this trial is testing

Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression

Who this might be right for
Bipolar DisorderDepressive Disorder
National Institute of Mental Health (NIMH) 75
Large-scale testing (Phase 3)Study completedNCT00048607
What this trial is testing

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

Who this might be right for
Major Depressive Disorder
Merck Sharp & Dohme LLC 600
Not applicableUnknownNCT05580198
What this trial is testing

Prognostic Markers of Post-Stroke Depression (PROMoSD)

Who this might be right for
Acute Ischemic Stroke
Ruhr University of Bochum 105
Post-approval studies (Phase 4)Study completedNCT01070329
What this trial is testing

A Study in Depression and Associated Painful Physical Symptoms

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 527
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Not applicableLooking for participantsNCT06687694
What this trial is testing

Immune Mechanisms of Antipsychotic Treatment Response

Who this might be right for
Psychosis
King's College London 500
Not applicableStudy completedNCT06601920
What this trial is testing

Activity Leader to Forest Therapy Campaign in Different Environments Targets on the Participants Which Had Been Infected by SARS-COV-2

Who this might be right for
Post COVID-19 SyndromeStress DisordersLife Quality+1 more
Taipei City Hospital 161
Not applicableStudy completedNCT01801631
What this trial is testing

Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital

Who this might be right for
Type 2 DiabetesAcute Coronary Event
UMC Utrecht 201
Not applicableStudy completedNCT02921828
What this trial is testing

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Who this might be right for
Multiple Myeloma
Celgene 1,149
Not applicableLooking for participantsNCT05923801
What this trial is testing

Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

Who this might be right for
Depression
Universitaire Ziekenhuizen KU Leuven 196
Not applicableNot Yet RecruitingNCT07667530
What this trial is testing

Probiotics for Depressive Symptomatology and Neural Activity.

Who this might be right for
Mild-to-moderate DepressionNeural ActivityExecutive Function (Cognition)
University of Reading 76
Not applicableUnknownNCT06064409
What this trial is testing

Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study

Who this might be right for
Respiratory InsufficiencyAcute Hypercapnic Respiratory FailureAcute Hypoxemic Respiratory Failure+7 more
Yonsei University 100
Not applicableStudy completedNCT04314115
What this trial is testing

Prevention of Mental Health Problems in People Exposed to a Recent Highly Stressful Event.

Who this might be right for
Posttraumatic Stress DisorderAcute Post-Traumatic Stress DisorderDepressive Symptoms
Universidad Santo Tomas, Chile 160
Not applicableStudy completedNCT04597086
What this trial is testing

Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients

Who this might be right for
Acute LeukemiaRecurrent LeukemiaRefractory Leukemia
Ohio State University Comprehensive Cancer Center 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT05690503
What this trial is testing

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Who this might be right for
Post-acute Sequelae of COVID-19Depressive SymptomsCognitive Dysfunction
New York State Psychiatric Institute 12
Next Page